Arthritis drug trial may only help the most critically iil coronavirus patients
Preliminary results of a study testing a rheumatoid arthritis drug disappointed after indicating it may only help the sickest coronavirus patients. Regeneron Pharmaceuticals Inc and Sanofi SA had been studying Kevzara in hopes it would mitigate the immune system’s overreaction to the virus, dampening hopes the medicine could benefit a wider group of those infected. … Read more